Gene · 684
Papers3,814
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,814
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Host Restriction Factors Modulating HIV Latency and Replication in Macrophages. | Int J Mol Sci | 2022 | 35328442 | PubTator, text mining | PubMed |
| Placental Neutrophil Infiltration Associated with Tobacco Exposure but Not Development of Bronchopulmonary Dysplasia. | Children (Basel) | 2022 | 35327753 | PubTator, text mining | PubMed |
| Radiolabeled Antibodies for Cancer Imaging and Therapy. | Cancers (Basel) | 2022 | 35326605 | PubTator, text mining | PubMed |
| Principles and Applications of CRISPR Toolkit in Virus Manipulation, Diagnosis, and Virus-Host Interactions. | Cells | 2022 | 35326449 | PubTator, text mining | PubMed |
| STxB as an Antigen Delivery Tool for Mucosal Vaccination. | Toxins (Basel) | 2022 | 35324699 | PubTator, text mining | PubMed |
| HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response. | Expert Rev Hematol | 2022 | 35322747 | PubTator, text mining | PubMed |
| TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection. | Front Biosci (Schol Ed) | 2022 | 35320917 | PubTator, text mining | PubMed |
| Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy. | EBioMedicine | 2022 | 35316682 | PubTator, text mining | PubMed |
| Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML. | Cancer Discov | 2022 | 35311997 | PubTator, text mining | PubMed |
| Let's Get Physical: Flavivirus-Host Protein-Protein Interactions in Replication and Pathogenesis. | Front Microbiol | 2022 | 35308381 | PubTator, text mining | PubMed |
| A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma. | Dis Markers | 2022 | 35308143 | PubTator, text mining | PubMed |
| Perfluoroalkyl substances influence DNA methylation in school-age children highly exposed through drinking water contaminated from firefighting foam: a cohort study in Ronneby, Sweden. | Environ Epigenet | 2022 | 35308102 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Duck plague virus UL41 protein inhibits RIG-I/MDA5-mediated duck IFN-β production via mRNA degradation activity. | Vet Res | 2022 | 35303942 | PubTator, text mining | PubMed |
| Therapeutic targeting miR130b counteracts diffuse large B-cell lymphoma progression via OX40/OX40L-mediated interaction with Th17 cells. | Signal Transduct Target Ther | 2022 | 35301282 | PubTator, text mining | PubMed |
| The Role of Long Noncoding RNA BST2-2 in the Innate Immune Response to Viral Infection. | J Virol | 2022 | 35297670 | PubTator, text mining | PubMed |
| Differently Expressed Circular RNAs in Lacrimal Sacs From Patients With Chronic Dacryocystitis. | Front Genet | 2022 | 35295950 | PubTator, text mining | PubMed |
| Computational identification of host genomic biomarkers highlighting their functions, pathways and regulators that influence SARS-CoV-2 infections and drug repurposing. | Sci Rep | 2022 | 35277538 | PubTator, text mining | PubMed |
| Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy. | Int J Mol Sci | 2022 | 35269844 | PubTator, text mining | PubMed |
| Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression. | Int J Gen Med | 2022 | 35264873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/684/papers?page=43